In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K | S-1/A |
Net income | -47.1 | -36.1 | -24.3 | 0.0 |
Depreciation and amortization [+] | 0.3 | 0.3 | 0.3 | 0.4 |
Depreciation | 0.3 | 0.3 | 0.3 | 0.4 |
Asset impairment charges | 0.2 | 0.2 | 0.3 | |
Stock-based compensation | 8.3 | 4.3 | 1.4 | 1.4 |
Change in working capital [+] | -2.7 | 0.4 | -2.1 | 0.5 |
Accounts receivable | -0.4 | 1.3 | -2.4 | -0.8 |
Inventories | -2.1 | -1.2 | 0.7 | -1.6 |
Other current assets | -0.8 | -1.2 | 0.1 | |
Accounts payable | 0.6 | 0.5 | 0.0 | -0.1 |
Accrued expenses | 0.0 | 1.7 | -0.7 | |
Other | | -0.8 | 0.2 | 3.0 |
Other operating activities | 4.0 | 6.3 | 2.7 | -27.4 |
Cash from operations | -36.9 | -24.6 | -21.6 | -25.0 |
|
Capital expenditures | -0.6 | -0.4 | -0.1 | -0.5 |
Purchases of property and equipment | -0.6 | -0.4 | -0.1 | -0.5 |
Purchases of short-term investments, net | 24.4 | -85.0 | -10.7 | 4.1 |
Purchases of short-term investments | | -85.0 | -17.0 | -18.0 |
Sales of short-term investments | 24.4 | | 6.3 | 22.1 |
Other cash from investing | | | | 0.0 |
Cash from investing | 23.8 | -85.4 | -10.8 | 3.6 |
|
Issuance of common stock, net | | 109.1 | | |
Option exercises | 0.9 | 0.9 | 0.0 | |
Financing costs | | | -1.0 | |
Other cash from financing | 1.4 | -5.6 | 54.1 | 21.4 |
Cash from financing | 0.5 | 102.5 | 55.0 | 21.4 |
|
Free cash flow | -37.5 | -25.0 | -21.7 | -25.5 |
Per share (diluted) | ($1.52) | ($1.50) | ($106.19) | ($0.13) |
|
Cash paid for interest | 4.5 | 6.3 | 4.4 | |